Related Research Articles
The Nurses' Health Study is a series of prospective studies that examine epidemiology and the long-term effects of nutrition, hormones, environment, and nurses' work-life on health and disease development. The studies have been among the largest investigations into risk factors for major chronic diseases ever conducted. The Nurses' Health Studies have led to many insights on health and well-being, including cancer prevention, cardiovascular disease, and type 2 diabetes. They have included clinicians, epidemiologists, and statisticians at the Channing Laboratory, Harvard Medical School, Harvard School of Public Health, and several Harvard-affiliated hospitals, including Brigham and Women's Hospital, Dana–Farber Cancer Institute, Children's Hospital Boston, and Beth Israel Deaconess Medical Center.
Betrixaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Betrixaban is FDA approved for venous thrombosis prevention in adults hospitalized for an acute illness who are at risk for thromboembolic complications. Compared to other directly acting oral anticoagulants betrixaban has relatively low renal excretion and is not metabolized by CYP3A4.
OpenNotes is a research initiative and international movement located at Beth Israel Deaconess Medical Center.
The STEPS trial was a clinical trial sponsored by Parke-Davis to evaluate the anticonvulsant Neurontin. It is notable for being a seeding trial to promote that drug and for contributing to the drug companies loss in the court case Franklin v. Parke-Davis.
Deborah Zarin is a program director at the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard University. She was formerly a scientist at the National Institutes of Health and the director of ClinicalTrials.gov.
Kathleen I. Pritchard, is the head of oncology at Sunnybrook Health Sciences Centre in Toronto, Canada, specializing in breast cancer therapies, and leading the clinical trials division of the centre. She has authored numerous studies on women's health, breast cancer, hormone replacement therapy, public health, and research methodology. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.
The 21st Century Cures Act is a United States law enacted by the 114th United States Congress in December 2016 and then signed into law on December 13, 2016. It authorized $6.3 billion in funding, mostly for the National Institutes of Health. The act was supported especially by large pharmaceutical manufacturers and was opposed especially by some consumer organizations.
Neil R. Powe is an American professor of medicine at the University of California, San Francisco and the chief of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center. Previously he was professor of medicine at the Johns Hopkins University School of Medicine. His research has mainly related to kidney disease, cardiovascular disease and health disparities.
Oriol Mitjà i Villar is a Catalan-born Spanish researcher and consultant physician in internal medicine and infectious diseases with expertise in poverty-related tropical diseases. He has conducted research at the Lihir Medical Centre in Papua New Guinea since 2010 on new diagnostic and therapeutic tools to eradicate yaws. He was awarded the Princess of Girona Award in the scientific research category. Currently at the Germans Trias i Pujol Research Institute, Mitjà is conducting research on SARS-CoV-2 coronavirus disease (COVID-19) and strategies to control the infection at a community level.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this, she was a professor at Yale, where she started the first refugee health clinic and homeless health mobile van project, for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine, emerging infectious diseases, women’s leadership in global health, and human and planetary health.
Fitzhugh Mullan was an American physician, writer, educator, and social activist. He participated in the founding of the Student Health Organization, the National Coalition for Cancer Survivorship, Seed Global Health, and the Beyond Flexner Alliance. Mullan was a professor of Health Policy and Management and of Pediatrics at the George Washington University and the George Washington University Health Workforce Institute, now renamed the Fitzhugh Mullan Institute for Health Workforce Equity. He was an elected member of the National Academy of Medicine.
Vineet M. Arora is an American medical researcher who is the Herbert T. Abelson Professor of Medicine and Assistant Dean for Scholarship and Discovery at the University of Chicago School of Medicine. She is a Fellow of the National Academy of Medicine. Her research considers clinical medicine and medical education, with a focus on the improvement of the quality of care in teaching hospitals.
Harlan M. Krumholz, MD, SM is an American cardiologist, leading research scientist, and the Harold H. Hines, Jr. Professor of Medicine at Yale School of Medicine, where he has been on faculty since 1992. A pioneer in the development of the field of outcomes research, his groundbreaking contributions to science have directly led to improvements in healthcare outcomes for patients and populations. He is an international expert in the science to evaluate and improve the quality and efficiency of care, reduce disparities, improve integrity in medical research, promote better health policies and regulations, and promote patient-centeredness in research and clinical care. He is the founder and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation.
Kathy Lynn Hudson is an American microbiologist specializing in science policy. She was the deputy director for science, outreach, and policy at the National Institutes of Health from October 2010 to January 2017. Hudson assisted in the creation and launch of All of Us, the BRAIN initiative, and the National Center for Advancing Translational Sciences. She founded the Genetics and Public Policy Center at Johns Hopkins University in 2002. Hudson is an advocate for women in science.
Claudio Tiribelli is an Italian hepatologist best known for his studies on bilirubin and Kernicterus, a bilirubin-induced neurological condition.
Fractional dose vaccination is a strategy to reduce the dose of a vaccine to achieve a vaccination policy goal that is more difficult to achieve with conventional vaccination approaches, including deploying a vaccine faster in a pandemic, reaching more individuals in the setting of limited healthcare budgets, or minimizing side effects due to the vaccine.
Sharon Kiyomi Inouye is an American geriatrician. She is the Director of the Aging Brain Center at the Hinda and Arthur Marcus Institute for Aging Research, as well as a professor of medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. Her career has focused on maintaining healthy brain aging, preventing delirium and functional decline, and optimizing healthcare for older adults. Her recent work has focused on healthy longevity and combating ageism.
Renee Yuen-Jan Hsia is an American emergency physician. She is a professor of Emergency Medicine and Associate Chair of Health Services Research at the University of California, San Francisco, as well as an attending physician in the emergency department at the Zuckerberg San Francisco General Hospital and Trauma Center. She is also a core faculty member of the UCSF Philip R. Lee Institute for Health Policy Studies. Her research is aimed at studying how health services and regionalization of care impact access to emergency care.
Carolyn Cannuscio is an American epidemiologist who is an associate professor at the Perelman School of Medicine. She serves as Director of Research for the Center for Public Health Initiatives. Cannuscio works to improve public health with a specific focus on disadvantaged urban populations.
Jenny Rosemary Vaughan is a British neurologist and co-lead of The Doctors' Association UK. She specialises in movement disorders, with a focus on Parkinson's disease. Alongside her research, Vaughan campaigns to improve justice within healthcare. She was made an Officer of the Order of the British Empire in the 2023 New Year Honours.
References
- ↑ Taichman, Darren B.; Backus, Joyce; Baethge, Christopher; Bauchner, Howard; de Leeuw, Peter W.; Drazen, Jeffrey M.; Fletcher, John; Frizelle, Frank A.; Groves, Trish; Haileamlak, Abraham; James, Astrid; Laine, Christine; Peiperl, Larry; Pinborg, Anja; Sahni, Peush; Wu, Sinan (28 January 2016). "Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors". New England Journal of Medicine. 374 (4): 384–386. doi:10.1056/NEJMe1515172. ISSN 0028-4793. PMC 4720169 . PMID 26786954.
- ↑ Herper, Matthew (30 January 2014). "In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers - Forbes". forbes.com. Retrieved 12 May 2015.
- ↑ Armstrong, Drew (31 January 2014). "J&J Sets Drug Data Free in 'YODA' Collaboration With Yale". bloomberg.com. Retrieved 12 May 2015.
- ↑ "Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine | Johnson & Johnson". www.jnj.com. Retrieved 22 August 2016.
- ↑ Hofheinz, Elizabeth. "Yale, SI-BONE Commence Data Transparency Project | Orthopedics This Week". ryortho.com. Retrieved 22 August 2016.
- ↑ "BioLINCC: Yale University Open Data Access Project (YODA)". National Heart, Lung, and Blood Institute. Retrieved 17 August 2016.
This article incorporates text from this source, which is in the public domain . - ↑ Shaikh, Abdul; Mutscher, Gus (4 August 2014). "Innovators in Health Data Series: The Yale Open Data Access (YODA) Project - Health Data Consortium". Health Data Consortium . Retrieved 12 May 2015.
- ↑ Krumholz, Harlan M.; Ross, Joseph S.; Gross, Cary P.; Emanuel, Ezekiel J.; Hodshon, Beth; Ritchie, Jessica D.; Low, Jeffrey B.; Lehman, Richard (2013). "A Historic Moment for Open Science: The Yale University Open Data Access Project and Medtronic". Annals of Internal Medicine. 158 (12): 910–911. doi:10.7326/0003-4819-158-12-201306180-00009. ISSN 0003-4819. PMC 5459387 . PMID 23778908.
